1. Implementation of an Adolescent & Young Adult Oncology (AYAO) Training Program at Oregon Health &Science University (OHSU) Lara E. Davis, MD1, Sue Lindemulder, MD2, Brandon HayesLattin, MD3, Linda Stork, MD2 Oregon Health & Science University, Portland, Oregon, USA 1Divisions of Medical Oncology and Pediatric Hematology/Oncology, 2Division of Pediatric Hematology/Oncology, 3Division of Medical Hematology/Oncology Introduction DiscussionThe need for oncologists with specialized training in adolescent Oregon Health & Scienceand young adult (15-39 years) oncology is a priority put forth by University currently has twothe 2006 National Cancer Institutes AYAO Progress Report fellows training in AYAO, oneGroup.1 Our institution created an AYAO fellowship program in each in the primary and2008 committed to training oncologists in both pediatric and alternate pathway. Interestadult oncology in order to improve access to care, create from fellowship applicants inrelevant clinical care models, and improve outcomes for the these training options hasAYAO population. been significant. A physician1 Albritton K, Caligiuri M, Anderson B, Nichols C, Ulman D. Closing the gap: Research and care imperatives for adolescents trained in Med-Peds interested OHSU AYA fellow trainee with patient.and young adults with cancer. Report of the adolescent and young adult oncology progress report group. Bethesda, MD:National Cancer Institute; 2006. in AYA oncology was selected Image courtesy of Nurse Oncology Education Program. to begin the primary pathway in July 2009. Application for dual training in Medical Oncology and Pediatric Hematology- Training Pathways Oncology was approved by the American Boards of Internal Medicine and Pediatrics. This fellows AYA training has entailedWe developed two AYAO training pathways. The primary one year in pediatric hematology-oncology and one year inpathway is designed as a 4-year program following completion medical oncology, followed by two years of lab-based researchof a combined Med-Peds residency. The alternate pathway is studying sarcomas. Continuity clinic has encompassed broadlydesigned as a supplemental year focused on AYAO that follows representative patients for the first two years, with a tailoredcompletion of a 3-year pediatric or medical hematology- AYA population for the second two years. Another pediatriconcology fellowship. The fellow has a faculty mentor in each of fellow began the supplemental year of the alternate pathway inthe two oncology departments. July 2011; she will continue mentored clinical research that involves an AYAO cohort treated in either the pediatric or adult programs at our institution. Combined Medical Oncology & Combined Internal Medicine – Pediatric Hematology/Oncology Pediatrics Residency Fellowship with AYA focus (4 years) (4 years) Medical School Pediatrics Residency or Hematology/Oncology AYA Internal Medicine Fellowship Fellowship Residency (3 years) (1 year) (3 years) ConclusionsThe training models developed and implemented at OHSU can be reproduced at other institutions andwill lead to broader access to quality AYAO clinical care, enhance AYAO-focused research, and increaseawareness of the unique challenges faced by the AYA population with cancer.